Foundational studies from the 1990s and early 2000s, such as those by Scott et al. (1994) and Counts and Mufson (2005), established that despite stable or even elevated NGF levels in the AD brain, cholinergic neurodegeneration persisted, suggesting a disruption in NGF processing or signalling pathways [21,22]. This evidence concerns the gene NGF and Alzheimer disease.